Coronavirus Update: Lilly Initiates 2,400-Patient Nursing Home Trial

 
• By Scrip Team

Dozens of specially outfitted RVs will roll out to long-term care facilities in the US to test the prophylactic and symptom-reducing potential of the antibody Lilly is developing with AbCellera.

3D_Coronavirus
LY-CoV555 is a neutralizing antibody against the SARS-CoV-2 spike protein

More from COVID-19

More from Scrip